SMS Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 3,019.83 million compared to INR 2,238.22 million a year ago. Revenue was INR 3,033.06 million compared to INR 2,252.37 million a year ago. Net income was INR 210.67 million compared to net loss of INR 147.75 million a year ago. Basic earnings per share from continuing operations was INR 2.49 compared to basic loss per share from continuing operations of INR 1.75 a year ago.